The Precision Peptide Co (FRA:XU0) ROC %: -689.02% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:XU0 The Precision Peptide Co Inc FRA:XU0
40 GF Score
Price €0.28
! 5 Warning Signs
View Full Analysis

What is The Precision Peptide Co ROC %?

The Precision Peptide Co FRA:XU0 40 ROC % is -689.02% as of Apr. 2026. GuruFocus rates FRA:XU0 with a GF Score™ of 40/100. The stock has 5 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The Precision Peptide Co's annualized return on capital (ROC %) for the quarter that ended in Apr. 2026 was -689.02%.

As of today (2026-07-16), The Precision Peptide Co's WACC % is 15.99%. The Precision Peptide Co's ROC % is -188.95% (calculated using TTM income statement data). The Precision Peptide Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

The Precision Peptide Co  (FRA:XU0) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, The Precision Peptide Co's WACC % is 15.99%. The Precision Peptide Co's ROC % is -188.95% (calculated using TTM income statement data). The Precision Peptide Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

The Precision Peptide Co ROC % Related Terms

The Precision Peptide Co ROC % Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co ROC % Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
ROC %
0.00 -337.72 -1,902.56 -5,347.83 -11,525.00

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.67 -93.96 -194.65 0.00 -689.02
FRA:XU0
40GF Score
The Precision Peptide Co Inc FRA:XU0
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co ROC % Calculation

The Precision Peptide Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Oct. 2025 is calculated as:

ROC % (A: Oct. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Oct. 2024 ) + Invested Capital (A: Oct. 2025 ))/ count )
=-1.383 * ( 1 - 0% )/( (0.012 + 0)/ 1 )
=-1.383/0.012
=-11,525.00 %

where

Invested Capital(A: Oct. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.121 - 0.477 - ( 0.093 - max(0, 0.489 - 0.121+0.093))
=0.012

Invested Capital(A: Oct. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.817 - 0.246 - ( 0.59 - max(0, 0.246 - 0.817+0.59))
=0

The Precision Peptide Co's annualized Return on Capital (ROC %) for the quarter that ended in Apr. 2026 is calculated as:

ROC % (Q: Apr. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2026 ) + Invested Capital (Q: Apr. 2026 ))/ count )
=-1.192 * ( 1 - 0% )/( (0 + 0.173)/ 1 )
=-1.192/0.173
=-689.02 %

where

Invested Capital(Q: Jan. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.402 - 0.236 - ( 0.256 - max(0, 0.236 - 0.402+0.256))
=0

Invested Capital(Q: Apr. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.929 - 0.275 - ( 0.481 - max(0, 0.275 - 0.929+0.481))
=0.173

Note: The Operating Income data used here is four times the quarterly (Apr. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -689.02% mean?
The Precision Peptide Co (FRA:XU0) has a ROC % of -689.02% as of Apr. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's ROC % too high?
The Precision Peptide Co's current ROC % is -689.02%. Overall, The Precision Peptide Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's ROC % compare to KHC and GIS?
The Precision Peptide Co's ROC % of -689.02% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROC % is 5.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Consumer Packaged Goods company?
The median ROC % among Consumer Packaged Goods companies is 5.19, based on 1,951 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on The Precision Peptide Co and its competitors. For the Consumer Packaged Goods industry, the median ROC % is 5.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Precision Peptide Co's current ROC % is -689.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (FRA:XU0) has a current ROC % of -689.02%. The current ROC % is -689.02%. The Precision Peptide Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For The Precision Peptide Co (FRA:XU0), the current ROC % is -689.02% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges PNGAF:USABPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
40GF Score

Get the complete analysis for FRA:XU0

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.28
Price